Exalgo Extended Release


Indications and Reactions:

Role Indications Reactions
Primary
Product Used For Unknown Indication 23.7%
Pain 21.1%
Back Pain 7.0%
Pain Management 6.1%
Cancer Pain 5.8%
Breakthrough Pain 5.1%
Supplementation Therapy 4.1%
Depression 3.9%
Hypertension 2.9%
Anxiety 2.7%
Neuralgia 2.7%
Constipation 1.9%
Diabetes Mellitus 1.9%
Insomnia 1.9%
Sleep Disorder 1.9%
Blood Cholesterol Increased 1.5%
Blood Pressure 1.5%
Foetal Exposure During Pregnancy 1.5%
Nausea 1.5%
Prostate Cancer 1.5%
Death 24.2%
Vomiting 11.1%
Pain 8.1%
Intentional Drug Misuse 6.1%
Respiratory Depression 6.1%
Suicide Attempt 6.1%
Incorrect Dose Administered 4.0%
Drug Screen Negative 3.0%
Influenza 3.0%
Irritability 3.0%
Nausea 3.0%
Rash 3.0%
Self Injurious Behaviour 3.0%
Urticaria 3.0%
Withdrawal Syndrome 3.0%
Accidental Exposure To Product 2.0%
Cancer Pain 2.0%
Convulsion 2.0%
Drug Diversion 2.0%
Extra Dose Administered 2.0%
Secondary
Product Used For Unknown Indication 17.1%
Pain 14.3%
Back Pain 6.8%
Pain Management 6.8%
Breakthrough Pain 6.0%
Constipation 5.2%
Cancer Pain 4.8%
Hypertension 4.8%
Nerve Block 4.0%
Neuralgia 4.0%
Prophylaxis 4.0%
Anxiety 3.6%
Depression 3.6%
Supplementation Therapy 3.6%
Acidosis 2.0%
Cough 2.0%
Diuretic Therapy 2.0%
Oedema 2.0%
Productive Cough 2.0%
Blood Cholesterol Increased 1.6%
Metastatic Pain 10.2%
Pain 10.2%
Vomiting 10.2%
Pancreatic Carcinoma 8.2%
Extra Dose Administered 6.1%
Influenza 6.1%
Suicide Attempt 6.1%
Death 4.1%
Formication 4.1%
Intentional Drug Misuse 4.1%
Memory Impairment 4.1%
Pneumonia 4.1%
Suicidal Ideation 4.1%
Urinary Tract Infection 4.1%
Weight Decreased 4.1%
Drug Withdrawal Syndrome 2.0%
Dyspnoea 2.0%
Dystonia 2.0%
Gastroenteritis Viral 2.0%
Humerus Fracture 2.0%

Drug Data